China NT Pharma Group Company Limited (NT Pharma) announced on 30 April 2026 that the English and Chinese versions of three key documents—the Annual Report 2025, a circular dated 30 April 2026 and the Notice of Annual General Meeting—have been released on both the company website (www.ntpharma.com) and Hong Kong Exchanges and Clearing’s website (www.hkexnews.hk).

Shareholders are encouraged to access the electronic versions; however, printed copies will be supplied free of charge upon request. Non-registered holders who wish to obtain hard copies must complete a request form and return it to the Hong Kong branch share registrar, Tricor Investor Services Limited, by post (17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong) or email (1011-ecom@vistra.com).

For non-registered shareholders, future notifications about corporate communications will be sent by email or post only if functional contact details are provided to the company via intermediaries such as banks, brokers, custodians or HKSCC Nominees Limited. Absent such details, no further notifications will be dispatched.

The current instruction to receive printed documents remains valid until 31 December 2026 unless amended in writing. Enquiries can be directed to the registrar’s hotline at +852 2980 1333 during business hours (Monday–Friday, 9:00 a.m.–6:00 p.m., excluding public holidays).